We are at War
The Brady Urological Institute is single-minded in its focus to eliminate the
scourge of prostate cancer.
This full-scale assault hinges on strong collaboration
among urologists, basic scientists, medical and radiation oncologists
and pathologists. Our goal is to recruit every talented scientist at
Johns Hopkins to join in this effort to conquer prostate cancer.
Over the past 20 years, progress in discovery
has skyrocketed. Today, we are on the verge of a major breakthrough in
understanding what causes prostate cancer, a discovery that will have
a profound impact on approaches to prevention and treatment.
At no time
in history has there been a greater opportunity to cure prostate cancer
and prevent future generations of our sons and grandsons from developing
the disease.
But Wars are Expensive
In our war against prostate cancer, we are pushing
back the enemy's front lines, and changing the course of this
disease. But wars are expensive. Fortunately, because of
private gifts, we have been able to make progress faster
than we ever could alone.
Patrick C. Walsh, M.D., has always believed that the
best way to tackle the multifaceted problem of prostate
cancer is to hit it hard from every possible angle and to
support those scientists who are in the trenches leading
the fight.
In recognition of this winning philosophy-and to
make certain that Dr. Walsh's vision continues-Johns
Hopkins has established The Patrick C. Walsh Prostate
Cancer Research Fund.
Killer Facts
Prostate cancer is a formidable enemy. It kills
fathers and grandfathers, sons and brothers. Worse, it is on the rise.
The disease is also much too common. This year
alone, an estimated 210,000 American men will be diagnosed with prostate
cancer, and 29,000 will die from it.
We find these numbers unacceptable.
The number of new cases of prostate cancer will
double and possibly triple unless we find some way to prevent this
disease.
Projected New Cases of Prostate Cancer
100,000 men will die unless we find new ways to cure prostate
cancer.
Historical and Projected Deaths of Prostate Cancer
Data from Chan, J. (unpublished)
How You Can Join the Fight
The Patrick C. Walsh Prostate
Cancer Research Fund will make it possible to attract and recruit the brightest scientists
from all disciplines at Johns Hopkins to join our fight against prostate
cancer.
Requests for research proposals will be distributed
each year to scientists throughout Johns Hopkins. A scientific advisory
board will award funding to projects holding the most promise.
The Walsh Fund has
two components:
An endowed fund for current research initiatives, fellows
and other research personnel.
A current use fund for new research initiatives,
equipment and laboratory expansion.
We invite you to participate in this initiative to
honor Dr. Walsh, and to further Hopkins’ effort to defeat prostate
cancer.
NAMING OPPORTUNITIES
$500,000 or more Donors who
give $500,000 or more will be recognized as Founders’ Circle members on the masthead
of the Brady Urological Institute’s annual letter and invited
to an annual program with scientists who were awarded funding.
$1,000,000 or more Donors
who give $1,000,000 or more will be members of the Founders’ Circle
and have the opportunity to create a Named Scholar award. These donors
will build a relationship with a scientist pursuing prostate cancer research
and have their names cited in the scientist’s published research
articles.
Nerve-sparing radical prostatectomy
